1 |
Fischer, P. B., G. B. Karlsson, R. A. Dwek and F. M. Platt (1996) N-butyldeoxynojirimycin-mediated inhibition ofHIV virus entry correlates with impaired gp120 shedding and gp41 exposure. J. Virol. 70, 7] 53-7160
|
2 |
Mehta, A., S. Carrouee, B. Conyers, R. Jordan, T. Butters, R.Dwek and T. M. Block (2001) Inhibition of HBV DNA repli-cation by imino sugars without the inhibition of the DNA polymerase- therapeutic implications. Hepatology 33, 1488-1495
DOI
ScienceOn
|
3 |
WHO. Hepatitis B. Fact Sheet WH0/204, November 1998
|
4 |
Blumberg, B. S. (1998) Hepatitis B virus: search for plant-derived antiviral; in Medical plants-their role in healh and biodiversity. Tomlinson T. R. and D. Akerele (eds.), PP. 7, University of Pennsylvania Press, Philadelphia
|
5 |
Purcell, R. H. (1990) The discovery ofthe hepatitis virus. Gas-troenteroloey 104, 955-963
|
6 |
Lu, X., A. Mehta, M. Dadmarz, R. Dwek, B. Blumberg and T. Block (1997) Aberrant trafficking of hepatitis B virus glyco-proteins in cells in which N-glycan processing is inhibited. Proc. Natl. Acad. Sci. USA 94, 2380-2385
DOI
ScienceOn
|
7 |
Sells, M. A., M. L. Chen and G. Acs (1987) Production of HBV virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84,1005-1009
DOI
ScienceOn
|
8 |
Lanford, R. E., Y. H. Kim, H. Lee, L. Notvall and B. Beames (1999) Mapping ofthe HBV reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and protein-protein interaction. J. Virol. 73, 1885-1893
|
9 |
Seeff, L. B., K. L. Lindsay, B. R. Bacon, T. F. Kresina and J. H. Hoofnagle (2001) Complementary and altemative medicine in chronic liver disease. Hepatology 34, 595-603
DOI
ScienceOn
|
10 |
Werr, M. and R. Prange (1998) Role for calnexin and N-linked glycosylation in the assembly and secretion of HBV virus middle envelope protein particles. J. Vtrol. 72, 778-782
|
11 |
Park, S. G. and G. Jung (2001) Human Hepatitis B Vims polymerase interacts with the molecular chaperonin Hsp60. J. Virol. 75, 6962-6968
DOI
ScienceOn
|
12 |
Korba, B. E. and J. L. Gerin (1992) Use of a standadized cell culture assay to assess activities of nucleoside analogs against HBV replication. Antiviral Res. 19, 55-70
DOI
ScienceOn
|
13 |
Zoulim, F. and C. Seeger (1994) Reverse transchption in hepa titis B virus is primed by a tyrosine residue of the poly-merase. J. Virol. 68, 6-13
|
14 |
Zitzmann, N., A. S. Mehta, S. Carrouee, T. D. Butters, F. M. Platt, J. McCauley, B. S. Blumberg, R. A. Dwek and T. M Block (1999) Imino sugars inhibit the formation and secre-tion of BVDV vims, a pestivims model of HCv: Implications for the development of broad spectrum anti-hepatitis vims agents. Proc. Natl. Acad. Sci. USA 96, 11878-11882
DOI
ScienceOn
|
15 |
Saunier, B., R. D. Kilker, J. S. Tkacz, A. Quaroni and A. Hers-covics (1982) Inhibition of N-linked complex oligosaccha-ride formation by l-DNJ, an inhibitor of processing glucosidases. J. Biol. Chem. 257, 14155-14161
|
16 |
Chen, R. W., H. Piparinen, M. Seppanen, P. Koskela, S. Sama and M. Lappalainen ( 2001) Real-time PCR for detection andquantitation of hepatitis B virus DNA. J. Med. Virol. 65, 250-256
DOI
ScienceOn
|
17 |
Hu, J. and C. Seeger (1996) Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 93, 1060-1064
DOI
ScienceOn
|
18 |
Korba, B. E. and G. Milman (1991) A cell culture assay for compounds which inhibit HBV replication. Antiviral Res. 15, 217-228
DOI
ScienceOn
|
19 |
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacte.nophage . Nature 227, 680-685
DOI
PUBMED
ScienceOn
|
20 |
Mehta, A., X. Lu, T. M. Block, B. S. Blumberg and R. A. Dwek (1997) HBV envelop glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alter-ation of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA 94, 1822-1827
DOI
ScienceOn
|
21 |
Wang, G. H. and C. Seeger (1992) the reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA syn-thesis. Cell 71, 663-670
DOI
ScienceOn
|
22 |
Zoulim, F, J. Saputelli and C. Seeger (1994) Woodchuck HBV virus X protein is required for viral infection in vivo. J. Virol.68, 2026-2030
|
23 |
Mehta, A., N. Zitzmann, P. Rudd, T. Block and R. Dwek (1998) Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Letter 430, 17-22
DOI
ScienceOn
|
24 |
Lanford, R. E., L. Notvall and B. Beames (1995) Nucleotide phming and reverse transcnptase activity of Hepatitis B Virus polymerase expressed in insect cells. J. Virol. 69, 4431-4439
|
25 |
Liaw, Y. F. (1997) Current trends in therapy for chronic viral hepatitis. J. Gastromterol. Hepatol. 12, S346-S353
DOI
ScienceOn
|
26 |
Liu, J. M., H. Lin and H. Mclntosh (2001) Genus Phyllanthus for chronic hepatitis B Virus infection: a systematic review. J. Viral Hepatitis 8, 358-366
DOI
ScienceOn
|